1. Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study. Issue 1 (January 2023) Authors: Blauvelt, Andrew; Pariser, David M.; Tyring, Stephen; Bagel, Jerry; Alexis, Andrew F.; Soung, Jennifer; Armstrong, April W.; Muscianisi, Elisa; Kianifard, Farid; Steadman, Jennifer; Sarkar, Rajendra Prasad; Garcet, Sandra; Krueger, James G. Journal: Journal of dermatological science Issue: Volume 109:Issue 1(2023) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗